We are live on ! Find out more
BGMSP

Bio Green Med Solution Inc Preferred Stock

Delisted

BGMSP was delisted on the 20th of March, 2026.

2 hedge funds and large institutions have $82K invested in Bio Green Med Solution Inc Preferred Stock in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.29% less ownership

Funds ownership: 4.2%3.91% (-0.29%)

9% less capital invested

Capital invested by funds: $90K → $82K (-$8K)

33% less funds holding

Funds holding: 32 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$4K
2
TRCT
Tower Research Capital (TRC)
New York
-$2.5K
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$82K
UBS Group
2
UBS Group
Switzerland
-$4K -609 Closed
TRCT
3
Tower Research Capital (TRC)
New York
-$2.5K -381 -90%

BGMSP Hedge Fund Activity: Q2 2017 in Review

2 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q2 2017, worth a combined $82K — down 8.9% from $90K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BGMSP and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was UBS Group, exiting entirely with an estimated $4K sold.

  • 2 institutional investors held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q2 2017, down from 3 in Q1 2017.
  • Funds reported $82K of Bio Green Med Solution Inc Preferred Stock stock for Q2 2017, down 8.9% quarter-over-quarter.
  • 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest Bio Green Med Solution Inc Preferred Stock seller in Q2 2017 was UBS Group, an estimated $4K sold.

Based on aggregated 13F filings for Q2 2017.